CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 235 enrolled
Drug / intervention
PF-05089771 +9 moredrug
Likely dose
PF-05089771 1600 mg oral solution, single doseAI-extracted
Key inclusion· 3
  • Underwent oral surgery removing 2 unilateral third molar teeth
  • Pre-dose pain intensity ≥50 mm on 100 mm VAS within 5 hours of surgery
  • Pre-dose pain rated as moderate or severe within 5 hours of surgery
Key exclusion· 6
  • Any clinically significant hematological, hepatic, renal, endocrine, cardiovascular, neurological, psychiatric, gastrointestinal, pulmonary, allergic, or metabolic disorder
  • Analgesic or NSAID use within 5 half-lives of that drug prior to first dose (except surgical anesthesia)
  • Active dental infection at time of surgery
  • Recent (within 12 months) chronic analgesic or tranquilizer dependency history

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01529346
NCT01529346Phase 2Completed

A Randomized, Double-blind, Double-dummy, Parallel Group, Placebo Controlled Study Assessing The Efficacy Of Single Doses Of Pf-05089771 For The Treatment Of Postoperative Dental Pain Using Ibuprofen 400 Mg As Positive Control

Pfizer·interventional·Posted Feb 8, 2012·Updated Jun 1, 2018

In Brief

A Phase 2 clinical trial evaluating PF-05089771, Placebo, and 1 other intervention for Postoperative Dental Pain. Completed, enrolled 235 participants across 3 sites.

Detailed Summary

The objective of this study is to evaluate the overall pain relief of a single dose of PF-05089771 against placebo following third molar extraction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 8, 2012
Enrollment StartDec 12, 2011
Primary CompletionJun 25, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.4 years ago

Interventions

PF-05089771drug

A single dose of PF-05089771 1600 mg oral solution administered once to the subject on Day 1 postoperatively

Placeboother

Placebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively

PF-05089771drug

A single dose of PF-05089771 450 mg oral solution administered once to the subject on Day 1 postoperatively

Placeboother

Placebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively

PF-05089771drug

A single dose of PF-05089771 150 mg oral solution administered once to the subject on Day 1 postoperatively

Placeboother

Placebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively

Ibuprofendrug

2 X 200 mg tablets of ibuprofen administered orally once to the subject on Day 1 postoperatively

Placeboother

Placebo solution for PF-05089771: A single dose of Placebo solution administered once to the subject on Day 1 postoperatively

Placeboother

Placebo solution for PF-05089771:A single dose of Placebo solution administered once to the subject on Day 1 postoperatively

Placeboother

Placebo tablets for Ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively